Alex,
Delusion is optional and I think it’s going to be substantially less than you think delusion is optional. It is going to be substantially less than you think. With approval in hand and European contracts in hand. A short term operating loan would less expensive with less new share holders.
seanearling10
Posts
-
-
Another great buying day! The shorts are giving all their money away. They can keep selling otlk but they won't be able to buy any. I don't usually lend my shares but I'm thinking of give the shorts enough rope to do the job. Like I said, this is a get day to buy, buy, buy…
-
The shorts are going through the roof!!! I ️ a good short squeeze. It just warms my heart.
-
We have exclusive approval and way more cash than we need to get to market. Europe is a multi billion market already using this product. These patient need the replacement for off label compounding ASAP. Do you really think the can wait until next year??? Statement of 2025 is just underpromising as to not getting sued. OTLK will over deliver being pushed by demand.
-
Buying, buying, buying… I love deals!
-
If you are dumb enough to sell now…. You clearly don't belong on the stock market. After you sell stamp yourself stupid and go find a broker.
-
We are on the money!!!!! The billion dollar premade make is ours and at what a price.
-
How exciting!!! We are about yo see a run on the shorts. We have all heard about it. We have all talked about it….. No you are going to see it!!!!
Its going to be epic. -
Franca, i think you meant to say $20 plus by May 27th. I think you you will find most analystswould agree that with approval $60-100 is more likely by end of year. Unlike other medications coming to market we already have a built in market already worth billions. This is a wholly unique opportunity that doesn’t come around very often if ever
-
Saltytimtation- off label gets no protection. The new medication will be pure and of standardized strength/potency. There will be no one wiling to compound off-label because of patent infringement. No providers will write off label for fear of medical malpractice. Insurance companies will not pay for it or insure providers that write it. To put it simple that even with the price increase.… this will be the cheapest and safest treatment available. Compounding off label will no longer exist which means 100% capture of that market.
-
Old news and already built into the price.
-
Frank, you selling short only creates shares you will have to cover later. When you are done in the kiddy sand box.… come play with the real investors. Price doesn't reflect value at this time.
-
The current price does not reflect its value. It is simply a reflection of daytraders and shorts upon the approval of EMA revenue will begin to be produced and an entirely different class of investor will be coming to the stock. Which point price corrections will begin to accelerate forward based on prebuilt market, and future revenues.
-
Syntone Ventures LLC is a major pharma distributor in the EU……just a little foreshadowing of things to come!
-
Waldo_III, that is your dumbest post yet. Hard to treat you like an experienced investor.
-
Frank, you keep saying garbage, but after all these years, you’re still here try to explain that one to us
-
Frank ~ go educate yourself. No one wants to read your outlandish statements. we prefer to deal with people that work in facts.
-
Just another day of shorts selling to shorts. True ling investors have not lost any money. True longs don't gamble on emotional daily swings. The real money is in bringing this product to market. Today's price diesnotvreforct the real value. Be patient and hold, approval is only days away.
-
I just bought me some more shares from a crazy short. I sure love getting good deals.
-
Isn't interesting how the shorts can always find a buyer at this price. I wonder if they think there will be sellers when the EU approval comes in a few days… like France Chance said it will be a lot of easy money for the longs. Sorry shorts you arecraking one to many rounds on the dance floor. You are going to play the fiddler his due.
OTLK
OTLK
OTLK
OTLK
OTLK
OTLK
OTLK
OTLK
OTLK
OTLK
OTLK
OTLK
OTLK
OTLK
OTLK
OTLK
OTLK
OTLK
OTLK
OTLK